Stay updated on Long-term Safety of KarXT in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.

Latest updates to the Long-term Safety of KarXT in Schizophrenia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new version entry 'Revision: v3.3.3' was added to the history, and two items—'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'—were removed; these are routine page maintenance updates and do not alter the study record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedNew revision version v3.3.2 appears in the Record History, replacing v3.2.0, and the visible study data and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe funding-status notice about government lapse in appropriations and NIH operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check60 days agoChange DetectedA new history version dated 2024-06-11 appears, listing updates to Study Status and Outcome Measures. This indicates ongoing maintenance of the trial record.SummaryDifference0.1%

- Check89 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference12%

- Check96 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%

Stay in the know with updates to Long-term Safety of KarXT in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of KarXT in Schizophrenia Clinical Trial page.